3 Matching Annotations
  1. Feb 2022
  2. news.sky.com news.sky.com
    COVID: Reinfection risk from Omicron 16 times higher than Delta, ONS data indicates
    1
    1. cheyennechooi 04 Feb 2022

      COVID: Reinfection risk from Omicron 16 times higher than Delta, ONS data indicates. (n.d.). Sky News. Retrieved February 4, 2022, from https://news.sky.com/story/reinfection-risk-from-omicron-16-times-higher-than-delta-ons-data-indicates-12519881

      is:article lang:en omicron variant COVID-19 reinfection vaccine rollout booster programme
    Visit annotations in context

    Tags

    Annotators

    URL

    news.sky.com/story/reinfection-risk-from-omicron-16-times-higher-than-delta-ons-data-indicates-12519881
  3. Dec 2021
  4. www.thelancet.com www.thelancet.com
    Emerging SARS-CoV-2 variants: shooting the messenger
    1
    1. lucyparfitt16 10 Dec 2021

      Diseases, T. L. I. (2021). Emerging SARS-CoV-2 variants: Shooting the messenger. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00770-2

      is:article lang:en COVID-19 variant Omicron South Africa government vaccine booster programme vaccine nonpharmaceutical intervention UK travel ban WHO blanket ban prevention economy restrictions surveillance resources global risk
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/laninf/article/PIIS1473-3099(21)00770-2/fulltext
  5. www.bmj.com www.bmj.com
    Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds
    1
    1. lucyparfitt16 06 Dec 2021

      Mahase, E. (2021). Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds. BMJ, 375, n3011. https://doi.org/10.1136/bmj.n3011

      is:article lang:en COVID-19 antibody vaccine booster immune response side effects research safety protection immunogenicity third dose booster programme UK T cell response immunity hospitalization mortality prevention half dose resources
    Visit annotations in context

    Tags

    Annotators

    URL

    bmj.com/content/375/bmj.n3011